Free Trial

MetaVia (MTVA) SEC Filings & 10K Form

MetaVia logo
$1.45 +0.08 (+5.84%)
As of 04/11/2025 03:51 PM Eastern

Recent MetaVia SEC Filings

DateFilerForm TypeView
04/04/2025
6:44 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 424B3
04/03/2025
11:15 PM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form EFFECT
03/27/2025
4:05 PM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form POS AM
03/27/2025
4:07 PM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
4:15 PM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
6:31 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:30 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:30 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
4:31 PM
Kim Hyung Heon (Reporting)
MetaVia Inc. (Issuer)
MetaVia Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
8:10 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:35 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
6:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:07 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:20 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:10 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form PRE 14A
07/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form EFFECT
07/24/2024
4:11 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 424B3
07/18/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/16/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
10:11 AM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4/A
06/26/2024
8:15 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:15 PM
DONG-A ST CO., LTD (Filed by)
NeuroBo Pharmaceuticals, Inc. (Subject)
NeuroBo Pharmaceuticals, Inc. (Subject)
MetaVia (Subject)
Form SC 13D/A
06/25/2024
3:16 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 424B5
06/25/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
STRICKLAND D GORDON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
Glickman Mark A (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
KOVEN ANDREW I (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
GROVES JASON L (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Salsbury Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:05 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Controversial opinion: Volume isn't enough. (Ad)

Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if supply is just as high. That’s why Tim Bohen created a new indicator designed to pinpoint stocks with high demand and low supply — the ideal setup for explosive moves.

Tim Bohen’s new indicator reveals the perfect trade setup: high demand, low supply.
04/30/2024
7:41 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form DEF 14A
04/30/2024
7:42 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form ARS
04/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form EFFECT
04/17/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:30 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:MTVA) was last updated on 4/12/2025 by MarketBeat.com Staff
From Our Partners